secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001493152-23-022531
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics President Amy Broidrick resigns; receives $360K annual severance for 12 months
--------------------------------------------------------------------------------

- Amy Broidrick resigned as President, Chief Strategy & Operating Officer and director effective June 16, 2023; departure not related to any disagreement.
- Separation agreement provides $16,636.79 for accrued salary/vacation and expense reimbursement.
- Severance of $360,000 annual salary continued for 12 months post-separation, plus COBRA coverage for 12 months.
- Broidrick has three months from separation to exercise vested stock options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223022531/0001493152-23-022531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315223022531/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer